Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CFSAN program priorities

This article was originally published in The Tan Sheet

Executive Summary

FDA requests public comment on the center's year 2000 program priorities in a Sept. 1 Federal Register. The deadline for comments is Sept. 30. FDA intends to make the new workplan public in January. The center continues work on its 1999 strategic plan "A-List" priorities, including resolution of issues involving ephedra-containing supplements, prompt review of new dietary ingredients, implementation of the authoritative statement provision of the FDA Modernization Act, development of an overall strategy on dietary supplements and issues involving third-party literature (1"The Tan Sheet" Feb. 1, p. 9). In July, CFSAN added to its "A List" development of a response strategy to the federal appeals court decision in Pearson v. Shalala (2"The Tan Sheet" July 12, In Brief)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090273

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel